Our Experience in Treating Infantile Hemangioma: Prognostic Factors for Relapse After Propranolol Discontinuation. [PDF]
Zaaroura H +3 more
europepmc +1 more source
Efficacy and safety assessment of propranolol tablets vs. oral solution for infantile hemangioma: a retrospective study in China. [PDF]
Chen W +8 more
europepmc +1 more source
Efficiency of Topical Beta-Blockers for Epistaxis Control in Ulcerated Infantile Hemangioma. [PDF]
Lam N, Schrepfer T.
europepmc +1 more source
Integrative Bioinformatics Analysis of Pyroptosis-Related Genes and Analysis of Immune Cell Infiltration in Infantile Hemangioma Regression. [PDF]
Liu L, Lin S, Bai J, Zhang B.
europepmc +1 more source
Psoriasiform rash possibly induced by oral propranolol in a 12-month-old girl with infantile hemangioma: a case report and literature review. [PDF]
Alruhaimi S, Alowirdi F, Al-Ajroush W.
europepmc +1 more source
Klebsiella pneumoniae-infected hemorrhagic ulcerative infantile hemangioma: A rare complication. [PDF]
Abtahi-Naeini B +4 more
europepmc +1 more source
Infantile hemangioma: the common and enigmatic vascular tumor. [PDF]
Holm A, Mulliken JB, Bischoff J.
europepmc +1 more source
Diagnosis and Treatment of Infantile Hemangioma from the Primary Care Paediatricians to the Specialist: A Narrative Review. [PDF]
Bellinato F +7 more
europepmc +1 more source
Infantile Hemangioma in Infancy: A Case Study on the Natural Course and Therapeutic Management. [PDF]
Gullabzada M +4 more
europepmc +1 more source

